Skip to content
  • About us
  • CYCLOPS
  • News
  • Products
  • Collaborations
  • Vacancies
  • Contact
Menu
  • About us
  • CYCLOPS
  • News
  • Products
  • Collaborations
  • Vacancies
  • Contact

Cyclops

  • Convenient
  • Reliable
  • Easy-to-use
  • Easy-to-carry
  • Hygienic
  • Less Cough
pureims-logo500px
  • About us
  • CYCLOPS
  • News
  • Products
  • Collaborations
  • Vacancies
  • Contact
Menu
  • About us
  • CYCLOPS
  • News
  • Products
  • Collaborations
  • Vacancies
  • Contact

PureIMS present at DDL2022

PureIMS will be present at the Drug Delivery to the Lungs Conference 2022 in Edinburgh. Please visit our stand (246) and have a chat.

We will be more than happy to tell you everything about our Cyclops™ single-use dry powder inhaler and hear all about your interesting projects too!

Furthermore, check out our posters on Epinephrine Cyclops™ (71) and Levodopa Cyclops™ (49).

SHARE THIS POST

Recent Posts

PureIMS names Frank Lambert to advance commercialization of its Cyclops™ Dry Powder Inhaler (DPI)

Fysisch-chemisch analist

Drug Delivery to the Lungs (DDL) poster on Epinephrine Cyclops™

PureIMS appoints Jaap Wieling, PhD, as new CEO

Levodopa Cyclops™ in Dutch magazine ‘Tijdschrift voor Neurologie en Neurochirurgie (TNN)’

PureIMS participating in Biotech Showcase™ 2022

Towards a cure for Mycobacterium abscessus disease using inhaled tigecycline

PureIMS to present at Biotech Showcase™ Digital 2021

Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops® High Dose Dry Powder Inhalation Device While Maintaining Dispersibility

PureIMS in Harro Magazine!

Categories

Categories
  • Press release (10)
  • Publication (2)
  • Scientific publication (5)
  • Status update (3)
  • Vacancies (1)

Contact Us

Ceintuurbaan Noord 152
9301 NZ Roden
The Netherlands
T: +31 (0)50 – 2053 325
F: +31 (0)50 – 2053 326
E: info@pureims.com

Social media

Linkedin Youtube

Making Inhaling Easier

CALL US NOW
© 2021 pureims